Delivering Products Healthcare Providers Can Rely On

About Lucent Diagnostics

Lucent Diagnostics, a commercial brand of Quanterix, was created in 2023 to deliver revolutionary tools that can aid in the earlier detection of cognitive disease. Powered by the ultra-sensitive SimoaTM technology, Lucent Diagnostics bridges the gap between research and clinical use by offering products and services designed specifically to meet the separate needs of institutions and healthcare providers. With more than a decade of proven success within the neurology research space, supported by thousands of publications and partnerships, Quanterix aims to directly impact the landscape of cognitive disease through its commercial brand, Lucent Diagnostics. Headquartered in Billerica, Massachusetts Lucent Diagnostics is comprised of: 

  • Dedicated leadership team 
  • On-site, CLIA certified lab with dedicated team  
  • Medical advisors and provider support team  
  • National field sales team 
  • National strategic accounts team  
  • Dedicated customer service team 

Certificates and accreditations

FAQ & Customer Notifications


Click a question below to read the answer.

About LucentAD

What is the LucentAD blood test?
What is measured in the LucentAD test?
Who should have the LucentAD test?
Alzheimer’s disease runs in my family. Should I get tested?

Getting the LucentAD Test

How do I get the LucentAD test?
What’s involved in getting the test?
Is the LucentAD test covered by insurance, Medicare or Medicaid?
How do I pay my bill?
How will I receive my results?
What will my results tell me?

Test Change Notifications

LucentAD Complete
LucentAD p-Tau 217
Lucent NfL
LucentAD p-Tau 181

Other Questions

What is Alzheimer’s disease?

Disclaimer

The information provided on this website is for educational purposes only and should not be considered as medical advice. Please consult with your healthcare provider for personalized guidance and treatment options.